HIV infection, highly active antiretroviral therapy and the cardiovascular system.
about
HIV-1 Tat protein directly induces mitochondrial membrane permeabilization and inactivates cytochrome c oxidaseCardiac Dysfunction Among Ugandan HIV-infected Children on Antiretroviral Therapy.Micronutrient concentrations and subclinical atherosclerosis in adults with HIV.Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross-sectional studyDiabetes, insulin resistance, and dementia among HIV-1-infected patientsNordihydroguaiaretic acid (NDGA) inhibits ritonavir-induced endothelial dysfunction in porcine pulmonary arteries.Effects of different types of exercise on body composition and fat distribution in HIV-infected patients: a brief review.Association between Immune Markers and Surrogate Markers of Cardiovascular Disease in HIV Positive Patients: A Systematic Review.Are HIV positive patients resistant to statin therapy?Disorders of glucose metabolism in the context of human immunodeficiency virus infection.IGF-IR in neuroprotection and brain tumors.Anolunula in Fingernails among Patients Infected with HIV.Impact of Highly Active Antiretroviral Therapy on paediatric Human Immunodeficiency Virus-associated left ventricular dysfunction within the Johannesburg teaching hospital complex.Myocardial infarction caused by pharmacological substances - case description and literature reviewAlcoholic Extract of Lotus Leaves Improves Lipid Profile in Rats with HIV Protease Inhibitor-induced DyslipidaemiaInsulin-like growth factor-I-forkhead box O transcription factor 3a counteracts high glucose/tumor necrosis factor-α-mediated neuronal damage: implications for human immunodeficiency virus encephalitis.Atherosclerosis and central adiposity in a pediatric patient with AIDS treated with HAART: autopsy findings.Frequency of Subclinical Atherosclerosis in Brazilian HIV-Infected Patients.EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment.Inhibitors of HIV-1 protease: 10 years after
P2860
Q28261913-59F6B102-8597-47DD-B7A2-E2F2BCBCA8C7Q30362434-04A88DDD-D0D5-4269-B90D-56C537DDA26DQ33790520-20B6BAE6-B58A-4029-8E14-EFA6891128A7Q33811250-FAF4B063-D872-45C0-B53E-161114750736Q34483421-EF9CA120-DD34-472C-B9A0-9E4DE6D97073Q35743832-929938FA-AA85-4F9D-B798-1F1C22ADF597Q36176266-792656B8-EA11-44DC-B2C8-BFE160DAFA79Q36249027-84D5A5B3-7AF6-4ABB-A5BA-F239F7898FD1Q36345121-6796B9EA-402B-45A1-8B25-99B53D6F738BQ36405647-7BF86373-7EAE-45A3-B4AD-3F973C43EF27Q37409955-89FA745B-FB14-4F82-9527-09DF2A1EACEDQ37632249-CB90F681-0E8E-4D1B-BBB1-0E6CFF8229B4Q37983204-C9471264-90FD-4A34-8312-767DFF9F55B0Q38191218-A1DFF337-5563-4651-B168-725098E99FB7Q38598879-AE1DFF2E-109B-4747-B06B-FF69F3BB9C6EQ41821482-7BD66038-AB1F-4867-9124-C864A23F40B1Q48340174-BCB9A3F0-D5B3-42EE-8DC0-D3B4B66BD01AQ55078006-1A78C2DF-124E-4D26-937F-5A80B231D273Q55255033-E30FAD77-5DFE-47C6-9CAE-F8E55E0368B1Q58389026-E5365F2C-6AF8-4215-B278-D65F6083E926
P2860
HIV infection, highly active antiretroviral therapy and the cardiovascular system.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
HIV infection, highly active antiretroviral therapy and the cardiovascular system.
@ast
HIV infection, highly active antiretroviral therapy and the cardiovascular system.
@en
type
label
HIV infection, highly active antiretroviral therapy and the cardiovascular system.
@ast
HIV infection, highly active antiretroviral therapy and the cardiovascular system.
@en
prefLabel
HIV infection, highly active antiretroviral therapy and the cardiovascular system.
@ast
HIV infection, highly active antiretroviral therapy and the cardiovascular system.
@en
P1476
HIV infection, highly active antiretroviral therapy and the cardiovascular system.
@en
P2093
Giuseppe Barbaro
P356
10.1016/S0008-6363(02)00828-3
P577
2003-10-01T00:00:00Z